An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Investigator: Bincy Abraham, MD

Study Coordinator:

Status: Enrolling Number: NCT03467958


Protocol Number: Pro00019983


This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.
More to Explore